SWTX (SpringWorks Therapeutics, Inc. Common Stock) Stock Analysis - Analyst Ratings

SpringWorks Therapeutics, Inc. Common Stock (SWTX) is a publicly traded Healthcare sector company. As of May 20, 2026, SWTX trades at $46.99 with a market cap of $3.48B and a P/E ratio of -13.78. SWTX moved +0.00% today. Year to date, SWTX is +29.45%; over the trailing twelve months it is +25.21%. Its 52-week range spans $28.21 to $62.00. Analyst consensus is buy with an average price target of $47.00. Rallies surfaces SWTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate SWTX?

11 analysts cover SWTX: 0 strong buy, 7 buy, 4 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $47.00.

SWTX Key Metrics

Key financial metrics for SWTX
MetricValue
Price$46.99
Market Cap$3.48B
P/E Ratio-13.78
EPS$-3.41
Dividend Yield0.00%
52-Week High$62.00
52-Week Low$28.21
Volume5.01M
Avg Volume0
Revenue (TTM)$219.67M
Net Income$-253.93M
Gross Margin93.23%

SWTX Analyst Consensus

11 analysts cover SWTX: 0 strong buy, 7 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $47.00.

Recent SWTX Insider Trades

  • Edris Badreddin sold 169.71K on Jul 1, 2025.
  • LYNCH DANIEL sold 93.00K on Jul 1, 2025.
  • Lewis-Hall Freda C sold 24.73K on Jul 1, 2025.

Common questions about SWTX

What do analysts rate SWTX?
11 analysts cover SWTX: 0 strong buy, 7 buy, 4 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $47.00.
Does Rallies show SWTX price targets?
Yes. Rallies tracks SWTX analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is SWTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SWTX. It does not provide personalized investment advice.
SWTX

SWTX